Rennova Health (RNVA)
(Delayed Data from OTC)
$0.00 USD
0.00 (0.00%)
Updated Sep 19, 2024 12:12 PM ET
NA Value
NA Growth NA Momentum NA VGMIncome Statements
Fiscal Year end for Rennova Health, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | NA | 13 | 3 | 7 | 16 |
Cost Of Goods | NA | 7 | 5 | 12 | 15 |
Gross Profit | NA | 6 | -2 | -5 | 1 |
Selling & Adminstrative & Depr. & Amort Expenses | 0 | 8 | 10 | 13 | 17 |
Income After Depreciation & Amortization | 0 | -1 | -13 | -17 | -16 |
Non-Operating Income | NA | 1 | 11 | 8 | -9 |
Interest Expense | NA | 2 | 3 | 10 | 22 |
Pretax Income | NA | -3 | -5 | -19 | -47 |
Income Taxes | NA | 0 | 0 | -1 | 0 |
Minority Interest | NA | 0 | 0 | 0 | 0 |
Investment Gains/Losses | NA | 0 | 0 | 0 | 0 |
Other Income/Charges | NA | 0 | 0 | 0 | 0 |
Income From Cont. Operations | NA | -3 | -5 | -18 | -47 |
Extras & Discontinued Operations | NA | 0 | 11 | -1 | -1 |
Net Income (GAAP) | NA | -3 | 6 | -18 | -48 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 0 | -1 | -12 | -16 | 1 |
Depreciation & Amortization (Cash Flow) | NA | 0 | 1 | 1 | 17 |
Income After Depreciation & Amortization | 0 | -1 | -13 | -17 | -16 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | NA | 9,992.24 | NA | 0.00 | 0.00 |
Diluted EPS Before Non-Recurring Items | NA | -0.03 | NA | NA | NA |
Diluted Net EPS (GAAP) | NA | -0.03 | -913.37 | NA | -0.03 |
Fiscal Year end for Rennova Health, Inc falls in the month of December .
All items in Millions except EPS data.
6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 | |
---|---|---|---|---|---|
Sales | NA | NA | NA | 3.54 | 6.39 |
Cost Of Goods | NA | NA | NA | 1.81 | 1.83 |
Gross Profit | NA | NA | NA | 1.73 | 4.56 |
SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | 2.34 | 2.46 |
Income After SG&A, R&D, and Dept/Amort Expenses | 0.00 | 0.00 | 0.00 | -0.61 | 2.10 |
Non-Operating Income | NA | NA | NA | 0.28 | 0.14 |
Interest Expense | NA | NA | NA | 0.42 | 0.43 |
Pretax Income | NA | NA | NA | -0.74 | 1.80 |
Income Taxes | NA | NA | NA | -0.18 | 0.52 |
Minority Interest | NA | NA | NA | -0.01 | 0.00 |
Investment Gains/Losses | NA | NA | NA | 0.00 | 0.00 |
Other Income/Charges | NA | NA | NA | 0.00 | 0.00 |
Income From Cont. Operations | NA | NA | NA | -0.56 | 1.28 |
Extras & Discontinued Operations | NA | NA | NA | 0.00 | -0.01 |
Net Income (GAAP) | NA | NA | NA | -0.55 | 1.28 |
Earnings Per Share Data | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | 6/30/23 |
---|---|---|---|---|---|
Average Shares | NA | NA | NA | 31,401.42 | NA |
Diluted EPS Before Non-Recurring Items | NA | NA | NA | 0.00 | 0.00 |
Diluted Net EPS (GAAP) | NA | NA | NA | 0.00 | 0.00 |